RESUMEN
Diarthrognathus broomi is a transitional taxon between non-mammaliaform cynodonts and Mammaliaformes that occurred during the Late Triassic to Early Jurassic. All known specimens of Diarthrognathus represent juveniles, and the postcrania have not been thoroughly described. The palatal, basicranial and postcranial elements of the referred specimen NMQR 1535 are described here for the first time using 3D reconstructions generated from X-ray micro-computed tomography (µCT) data. The presence of a large interpterygoid vacuity, open medial suture between the vomers and medially unossified secondary palate all support the interpretation that NMQR 1535 is a juvenile. In addition, Diarthrognathus uniquely possesses "suborbital" vacuities, which distinguishes it from every other known cynodont. The presence of an ossified olecranon process, among other features, suggests that Diarthrognathus may have been a scratch-digger. The postcranial skeleton of Diarthrognathus appears to be more plesiomorphic than tritylodontids, Brasilodon and other tritheledontids as, among other traits, it retains amphicoelous vertebrae. However, this taxon also displays synapomorphies with the more derived cynodonts, such as the mammalian pattern of neurocentral ossification and possible absence of an ectepicondylar foramen.
Asunto(s)
Evolución Biológica , Fósiles , Animales , Microtomografía por Rayos X , Mamíferos , Hueso Paladar/diagnóstico por imagenRESUMEN
Regulatory T cells (T(regs)) play a pivotal role in preventing autoimmunity, graft-versus-host disease (GVHD), and organ graft rejection. We previously showed that either germline or induced SH2 domain-containing inositol 5-phosphatase (SHIP) deficiency in the host abrogates GVHD. Here we show that SHIP deficiency promotes an increase of CD4(+)CD25(+)FoxP3(+) T(regs) and CD4(+)CD25(-)FoxP3(+)"naive" T cells in the periphery that display increased CD103, glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), OX40, and FcgammaRII/III expression. SHIP deficiency does not compromise T(reg) function because SHIP-deficient CD3(+)CD4(+)CD25(+) T(regs) are as suppressive as wild-type (WT) CD3(+)CD4(+)CD25(+) T(reg). Interestingly, like conventional T(regs), SHIP(-/-) CD4(+)CD25(-) T cells are unresponsive to major histocompatibility complex (MHC)-mismatched stimulators and suppress allogeneic responses by T cells in vitro. In addition, SHIP(-/-) CD4(+)CD25(-) T cells mediate reduced lethal GVHD on adoptive transfer to MHC-mismatched hosts. Furthermore, hosts with induced SHIP deficiency exhibit delayed rejection of MHC-mismatched cardiac grafts. Thus, SHIP is required for robust graft-versus-host and host-versus-graft responses by CD4(+) T cell and limits their immunoregulatory capacity. These findings further define the immunosuppressive mechanisms that result from SHIP deficiency and provide additional justification for targeting SHIP in clinical transplantation.